Patents by Inventor Wayne R. Danter

Wayne R. Danter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein tyrosine kinase inhibitors
    Patent number: 7585866
    Abstract: The present invention relates to compounds of the Formula I, the pharmaceutically acceptable salts and stereoisomers thereof, which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions in mammals: wherein n is an integer, preferably n is 1; wherein R1 and R2 are independently selected from the group consisting of:
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: September 8, 2009
    Assignee: Critical Outcome Technologies, Inc.
    Inventors: Wayne R. Danter, Martyn Brown, George Ma, Ghenadie Rusu, Jianhua Zhong, Natalie Lazarowych, Stephen Houldsworth
  • COMPOUNDS AND METHOD FOR TREATMENT OF CANCER
    Publication number: 20080171744
    Abstract: The present invention is directed to a compound of Formula I: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, or combination thereof, a composition comprising the thiosemicarbazone, a method of administration thereof, and use thereof to treat a cancer.
    Type: Application
    Filed: January 11, 2008
    Publication date: July 17, 2008
    Applicant: 6441513 CANADA INC.
    Inventors: Wayne R. Danter, Martyn Brown, Franck LePifre